FemTab 1mg tablets

Ülke: Birleşik Krallık

Dil: İngilizce

Kaynak: MHRA (Medicines & Healthcare Products Regulatory Agency)

Aktif bileşen:

Estradiol valerate

Mevcut itibaren:

Merck Serono Ltd

ATC kodu:

G03CA03

INN (International Adı):

Estradiol valerate

Doz:

1mg

Farmasötik formu:

Oral tablet

Uygulama yolu:

Oral

Sınıf:

No Controlled Drug Status

Reçete türü:

Valid as a prescribable product

Ürün özeti:

BNF: 06040101

Bilgilendirme broşürü

IF YOU TAKE MORE PROGYNOVA THAN YOU SHOULD
Overdose may cause nausea and vomiting and irregular bleeding.
No specific treatment is necessary but you should consult your
doctor or pharmacist if you are concerned.
IF YOU FORGET TO TAKE PROGYNOVA
If you forget to take a tablet at your usual time and you are less
than 12 hours late, take it as soon as possible. Take the next tablet
at the usual time.
If you are more than 12 hours late, leave the forgotten tablet in the
pack. Continue to take the rest of the tablets at the usual time every
day. You may experience breakthrough bleeding.
IF YOU STOP TAKING PROGYNOVA
You may begin to feel the usual symptoms of menopause again,
which may include hot flushes, trouble sleeping, nervousness,
dizziness or vaginal dryness. Consult your doctor or pharmacist if
you want to stop taking Progynova tablets.
IF YOU NEED TO HAVE SURGERY
If you are going to have surgery, tell the surgeon that you are taking
Progynova. You may need to stop taking Progynova about 4 to 6
weeks before the operation to reduce the risk of a blood clot (see
section 2, “Blood clots in a vein (thrombosis)”).
Ask your doctor when you can start taking Progynova again.
If you have any further questions on the use of this medicine, ask
your doctor or pharmacist.
4. POSSIBLE SIDE EFFECTS
Like all medicines, this medicine can cause side effects, although
not everybody gets them.
The following diseases are reported more often in women using
HRT compared to women not using HRT:
SERIOUS SIDE EFFECTS

breast cancer

abnormal growth or cancer of the lining of the womb
(endometrial hyperplasia or cancer)

ovarian cancer

blood clots in the veins of the legs or lungs (venous
thromboembolism)

heart disease

stroke

probable memory loss if HRT is started over the age of 65
For more information about these side effects see section 2.
OTHER SIDE EFFECTS that have been linked to the use of Progynova
and other oral hormone replacement therapies:

During the first few months of treatment you may experi